and potentially extending access to around 1.2 million people.
Metabolic differences in response to a high-fat vs
Smith PA, Sakura H, Coles B, Gummerson N, Proks P, Ashcroft FM
Leukocyte and neutrophil mean cell counts remained within normal range between screening, baseline and throughout the pivotal Phase 3 (leukocytes: normal range 4.010.0 109/L mean count at Day 182: 6.6 109/L with garadacimab [n = 39], 6.2 109/L with placebo [n = 24], neutrophils: normal range 2.07.0 109/L, mean count at Day 182: 4.0 109/L with garadacimab, 3.9 109/L with placebo) and OLE studies (At Month 12 [n = 140]: leukocytes: 6.4 109/L
While Ozempic, a brand name for semaglutide, is not FDA-approved for weight loss, the brand name Wegovy holds specific FDA approval for this purpose